Recombinant Human ICOS ligand(ICOSLG),partial (Active)
Recombinant Human ICOS ligand(ICOSLG),partial (Active)

Western blot analysis of beta actin in COS7, Jurkat, C6 and 3T3 lysates using beta actin antibody (1:5000 diluted).

Recombinant Human ICOS ligand(ICOSLG),partial (Active)
Cat:
GS13164
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Type:
Protein
Alias:
B7 homolog 2 (B7-H2) (B7-like protein Gl50) (B7-related protein 1) (B7RP-1)
Expressed Host:
Mammalian cell
Species:
Homo sapiens (Human)
Price:
  • Product details
Product Name
Recombinant Human ICOS ligand(ICOSLG),partial (Active)
Cat
GS13164
Expression Region
Uniorot ID:O75144(19-258aa)
Alias
B7 homolog 2 (B7-H2) (B7-like protein Gl50) (B7-related protein 1) (B7RP-1)
Expressed Host
Mammalian cell
Species
Homo sapiens (Human)
Tag
C-terminal 6xHis-tagged
Purity
Greater than 93% as determined by SDS-PAGE.
Endotoxin
Less than 1.0 EU/ug as determined by LAL method.
Buffer
Lyophilized from a 0.2 μm filtered 20 mM Tris-HCl, 0.5 M NaCl, 6% Trehalose, pH 8.0
Biological activity
Measured by its binding ability in a functional ELISA. Immobilized ICOSLG at 2 μg/ml can bind human ICOS (CSB-MP707478HU), the EC50 of human ICOSLG protein is 29.04-43.59 ng/ml.
Storage
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Type
Protein
Purposes
For research use only